1 week Ago
A U.S. district judge on Thursday denied an injunction sought by a compounding industry group to keep making cheaper versions of Novo Nordisk’s ( NVO ) weight loss drugs Ozempic and Wegovy, even after the FDA declared that the GLP-1s are no.
